Search results :

Loperamide

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: A07DA03

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12
Constipation postmarketing, 1.6% - 5.3% 0% - 5.3% x x x x x x x x x x x x
Abdominal cramps 0.5% - 3% x x x x x x x x x x x
Nausea postmarketing, 0.7% - 3.2% x x x x x x x x x x x x
Abdominal distension postmarketing x x x x
Abdominal pain postmarketing x x x x x x x x x x x x
Anaphylactic shock postmarketing x x x x x x x x x x x
Angioedema postmarketing x x x x x x x x x x x
Distention postmarketing x x x x x x x x
Dizziness postmarketing, 1.4% 0.7% - 1.4% x x x x x x x x x x x x
Drowsiness postmarketing x x x x x x x x x x x x
Dyspepsia postmarketing x x x x x x x x x x x
Toxic epidermal necrolysis postmarketing x x x x x x x x x x x
Erythema multiforme postmarketing x x x x x x x x x x x
Rash postmarketing x x x x x x x x x x x x
Fatigue postmarketing x x x x x x x x x x x x
Flatulence postmarketing x x x x x x x x x x x
Gastrointestinal disorder postmarketing x x x x x x x x x
Hypersensitivity postmarketing x x x x x x x x x x x x
Immune system disorder postmarketing x x x x x x x x x
Megacolon postmarketing x x x x x x x x x x x
Megacolon toxic postmarketing x x x x x x x x x x x
Nervous system disorder postmarketing x x x x x x x x x
Ileus paralytic postmarketing x x x x x x x
Pruritus postmarketing x x x x x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x x x x x x
Loss of consciousness postmarketing x x x x
Urinary tract disorder postmarketing x x x x x x x x x
Urticaria postmarketing x x x x x x x x x x x
Vomiting postmarketing x x x x x x x x x x x x
Dry mouth postmarketing x x x x x x x x x x x x
Urinary retention postmarketing x x x x x x x x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x x x x x x
Discomfort postmarketing x x x x x x x x x x x x
Bullous eruption postmarketing x x x x x x x x x x x
Anaphylactoid reaction postmarketing x x x x x x x x x x x
Depressed level of consciousness postmarketing x x x x
Ileus postmarketing x x x x
Headache x x x x x x x x
Abdominal colic x x x x x x x x
Epigastric pain x
Acute diarrhea x x x x x x x x x x x
Abdominal bloating x x x x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

LOPERAMIDE HYDROCHLORIDE / LOPERACAP

Side effects:13
Source:Health Canada

LOPERAMIDE

Side effects:32
Source:FDA Structured Product Label

Loperamide

Side effects:32
Source:FDA Structured Product Label

LOPERAMIDE

Side effects:37
Source:FDA Structured Product Label

LOPERAMIDE

Side effects:37
Source:FDA Structured Product Label

LOPERAMIDE

Side effects:37
Source:FDA Structured Product Label

Loperamide

Side effects:37
Source:FDA Structured Product Label

loperamide hydrochloride / Imodium

Side effects:37
Source:FDA

Loperamide capsules / Diamide Relief, Capsule

Side effects:36
Source:Medsafe

LOPERAMIDE HYDROCHLORIDE / IMODIUM

Side effects:39
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label